Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Restricted Stock (Details)

v3.20.4
Stock-Based Compensation - Restricted Stock (Details) - Restricted Stock - $ / shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Number of Unvested Shares    
Equity Instruments outstanding, beginning balance (in shares) 1,768,726 0
Granted during period (in shares) 657,135 1,805,222
Vested during period (in shares) (1,047,972) (36,496)
Forfeited during period (in shares) 0 0
Equity Instruments outstanding, ending balance (in shares) 1,377,889 1,768,726
Weighted Average Grant Date Fair Value per Share    
Weighted average grant date fair value, RSUs outstanding, beginning balance (in usd per share) $ 2.6 $ 0
Weighted average grant date fair value, RSUs outstanding, granted in period (in usd per share) 2.9 2.6
Weighted average grant date fair value, RSUs outstanding, exercised in period (in usd per share) 2.6 2.7
Weighted average grant date fair value, RSUs outstanding, forfeitures during period (in usd per share) 0 0
Weighted average grant date fair value, RSUs outstanding, ending balance (in usd per share) $ 2.7 $ 2.6